Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New proton beam combo aims to shrink inoperable pancreatic tumors enough for surgery

NCT ID NCT02598349

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 29 times

Summary

This study is for people with pancreatic cancer that cannot be surgically removed. It tests whether giving a higher dose of proton radiation along with the oral chemotherapy drug capecitabine can help more patients become eligible for surgery and improve survival. About 60 participants will receive this combined treatment to see if it works better than past results.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Inova Schar Cancer Institute

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • McLaren Proton Therapy Center

    RECRUITING

    Flint, Michigan, 48532, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Northwestern Medicine Chicago Proton Center

    RECRUITING

    Warrenville, Illinois, 60555, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Florida Proton Therapy Institute

    ACTIVE_NOT_RECRUITING

    Jacksonville, Florida, 32206, United States

Conditions

Explore the condition pages connected to this study.